Last reviewed · How we verify

NCT04227587

Effects of Zero-Time Exercise (ZTEx) on Inactive Adults With Insomnia Disorder

Completed NA Last updated 12 June 2023
What this trial tests

NA trial testing Zero Time Exercise in Insomnia, Primary in 140 participants. Completed in 30 June 2022.

Timeline
1 September 2020
Primary endpoint
30 April 2022
30 June 2022

Quick facts

Lead sponsorThe Hong Kong Polytechnic University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment140
Start date1 September 2020
Primary completion30 April 2022
Estimated completion30 June 2022
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The Hong Kong Polytechnic University

Who can join

Adults 18 to 65, any sex, with Insomnia, Primary. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial (RCT) with a longitudinal mixed-method process evaluation aims to (1) determine the effectiveness of a ZTEx intervention program, which is a lifestyle-integrated physical activity program, on sleep and related outcomes in inactive adults with insomnia disorder

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of zero-time exercise on physically inactive adults with insomnia disorder: A randomized controlled trial.
    Yeung WF, Lai AY, Yu BY, Ho FY, et al · · 2025 · cited 5× · PMID 39999728 · DOI 10.1016/j.ijnurstu.2025.105033

Verify or expand the search:

Other trials of Zero Time Exercise

Trials testing the same drug.

Other recruiting trials for Insomnia, Primary

Currently open trials in the same condition.

Other The Hong Kong Polytechnic University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04227587.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing